These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12794146)

  • 1. Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice.
    Saeland E; Vidarsson G; Leusen JH; Van Garderen E; Nahm MH; Vile-Weekhout H; Walraven V; Stemerding AM; Verbeek JS; Rijkers GT; Kuis W; Sanders EA; Van De Winkel JG
    J Immunol; 2003 Jun; 170(12):6158-64. PubMed ID: 12794146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
    McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
    J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.
    Mold C; Rodic-Polic B; Du Clos TW
    J Immunol; 2002 Jun; 168(12):6375-81. PubMed ID: 12055255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against pneumococcal infection elicited by immunization with multiple pneumococcal heat shock proteins.
    Cao J; Zhang X; Gong Y; Zhang Y; Cui Y; Lai X; Yin Y; Li M; Li D; Zhang L
    Vaccine; 2013 Aug; 31(35):3564-71. PubMed ID: 23727004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.
    Tian H; Groner A; Boes M; Pirofski LA
    Infect Immun; 2007 Apr; 75(4):1643-50. PubMed ID: 17220309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.
    Weber S; Tian H; van Rooijen N; Pirofski LA
    Infect Immun; 2012 Apr; 80(4):1314-22. PubMed ID: 22290146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with LytB protein of Streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis.
    Corsini B; Aguinagalde L; Ruiz S; Domenech M; Antequera ML; Fenoll A; García P; García E; Yuste J
    Vaccine; 2016 Dec; 34(50):6148-6157. PubMed ID: 27840016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide.
    Burns T; Abadi M; Pirofski LA
    Infect Immun; 2005 Aug; 73(8):4530-8. PubMed ID: 16040964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults.
    Lortan JE; Kaniuk AS; Monteil MA
    Clin Exp Immunol; 1993 Jan; 91(1):54-7. PubMed ID: 8419085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal pneumonia and bacteremia model in mice for the analysis of protective antibodies.
    Saeland E; Vidarsson G; Jonsdottir I
    Microb Pathog; 2000 Aug; 29(2):81-91. PubMed ID: 10906263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
    Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.
    Caro-Aguilar I; Indrawati L; Kaufhold RM; Gaunt C; Zhang Y; Nawrocki DK; Giovarelli C; Winters MA; Smith WJ; Heinrichs J; Skinner JM
    Vaccine; 2017 Feb; 35(6):865-872. PubMed ID: 28087148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of leukocyte immunoglobuin G receptors in vaccine-induced immunity to Streptococcus pneumoniae.
    Saeland E; Leusen JH; Vidarsson G; Kuis W; Sanders EA; Jonsdottir I; van de Winkel JG
    J Infect Dis; 2003 Jun; 187(11):1686-93. PubMed ID: 12751025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal Deoxynucleotidyl Transferase Is Not Required for Antibody Response to Polysaccharide Vaccines against Streptococcus pneumoniae and Salmonella enterica Serovar Typhi.
    Belde V; Cravens MP; Gulandijany D; Walker JA; Palomo-Caturla I; Alugupalli AS; Sandilya VK; Mahmoud T; Bäumler AJ; Kearney JF; Alugupalli KR
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29967094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunization with purified ClpP could elicit protective efficacy against pneumococcal pneumonia and sepsis in mice.
    Cao J; Chen T; Li D; Wong CK; Chen D; Xu W; Zhang X; Lam CW; Yin Y
    Microbes Infect; 2008; 10(14-15):1536-42. PubMed ID: 18930162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.
    Tian H; Weber S; Thorkildson P; Kozel TR; Pirofski LA
    Infect Immun; 2009 Apr; 77(4):1502-13. PubMed ID: 19168739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG2 subclass restriction of antibody to pneumococcal polysaccharides.
    Barrett DJ; Ayoub EM
    Clin Exp Immunol; 1986 Jan; 63(1):127-34. PubMed ID: 3955880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
    Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
    J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between in vitro complement deposition and passive mouse protection of anti-pneumococcal surface protein A monoclonal antibodies.
    Khan N; Qadri RA; Sehgal D
    Clin Vaccine Immunol; 2015 Jan; 22(1):99-107. PubMed ID: 25410204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
    Xu Q; Surendran N; Verhoeven D; Klapa J; Ochs M; Pichichero ME
    Vaccine; 2015 Feb; 33(8):993-1000. PubMed ID: 25597944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.